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No statistical method was used to predetermine sample size. For the EAE model, we included all available mice. For the IBD model, we followed standard protocols used by our collaborators, who are experts in this area. For all other experiments, we followed recommended sample size from well established protocols. All experiments were repeated, as indicated.
No data was excluded from this study. For all in vitro experiments with retroviral transduction, same genotype mice are pooled then in vitro differentiated cells were equally allocated to different treatment groups. Mice are sex-and age-matched and are randomly assigned to different treatment and control groups. For the KO mice, control WT litter mates were used for comparisons.
For all in vivo and individual mouse in vitro differentiation experiments, all the mice were coded and the data collection such as clinical score for EAE, or flow cytometery analysis was performed in blind fashion without the knowledge of the codes. For all in vitro experiments involving retroviral transductions, cells were pooled from the same genotype mice. Not all in vitro experiments were blinded but all were repeated as indicated. We do not believe that blinding is always necessary for these experiments nor is it always practical for all experiments in standard individual laboratories.
PerCP/Cy5.5 anti-CD25 (Biolegend, Clone PC61), PE anti-IL12Rb2 (Miltenyi Biotec, Clone REA200), APC anti-IFNg (Biolegend, CloneXMG1.2), or BV421 anti-T-bet (Biolegend, Clone 4B10), anti-FLAG (M2) antibody (Sigma, clone M2), anti-p73 antibody (Abcam, cloneEP436Y), FITC anti-TCRb (eBioscience, Clone H57-597), PE/Cy5 and FITC anti-CD4(eBioscience, Clone GK1.5), APC anti-IL17A (eBioscience, Clone B7), PE anti-CD45RB (eBioscience, Clone C363.16A).
All fluorophore conjugated antibodies are against mouse protein and used for flow cytometry. Anti-FLAG antibody is not species specific and used for western blotting and immunoprecipitation. Anti-p73 antibody is against human and mouse protein, and was used for western blotting and immunoprecipitation. All antibodies used in this study are commercially available, and the validations were completed by the manufacturers. Animals and other organisms Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals
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